Tortoise Investment Management, LLC Gilead Sciences, Inc. Transaction History

Tortoise Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $15,202 - $17,340	-200 Reduced 81.63%	45 $3,000
Q2 2022 Aug 03, 2022	SELL	$57.72 - $65.01 $11,544 - $13,002	-200 Reduced 44.94%	245 $15,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $11,330 - $12,910	200 Added 81.63%	445 $26,000
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $30,382 - $35,280	-420 Reduced 63.16%	245 $19,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $12,839 - $16,445	205 Added 44.57%	665 $50,000
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $25,572 - $28,128	415 Added 922.22%	460 $30,000
Q3 2019 Nov 06, 2019	SELL	$62.51 - $69.0 $25,941 - $28,635	-415 Reduced 90.22%	45 $3,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $136,137 - $165,967	-1,869 Reduced 80.25%	460 $35,000
Q4 2017 Jan 31, 2018	BUY	$71.15 - $83.52 $4,909 - $5,762	69 Added 3.05%	2,329 $167,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $162,968 - $193,162	2,260	2,260 $183,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tortoise Investment Management, LLC with notifications on news.